Paper28736635
Immunotherapy in gastrointestinal cancers.
Grierson P and 2 others. J Gastrointest Oncol, 2017. Cited by 41 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Immunotherapy in gastrointestinal cancers. Papers, record 28736635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28736635
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20119674 | Pilot study of sentinel-node-based adoptive immunotherapy in advanced colorectal cancer. | Ann Surg Oncol | 2010 | https://conductscience.org/library/papers/20119674 | PubMed |
| 2 | 27376576 | Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. | Nat Med | 2016 | https://conductscience.org/library/papers/27376576 | PubMed |
| 3 | 26541610 | Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. | Science | 2015 | https://conductscience.org/library/papers/26541610 | PubMed |
| 4 | 12800259 | In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma. | World J Gastroenterol | 2003 | https://conductscience.org/library/papers/12800259 | PubMed |
| 5 | 25584002 | Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/25584002 | PubMed |
| 6 | 12854132 | Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer. | World J Gastroenterol | 2003 | https://conductscience.org/library/papers/12854132 | PubMed |
| 7 | 20333377 | Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. | Cancer Immunol Immunother | 2010 | https://conductscience.org/library/papers/20333377 | PubMed |
| 8 | 27959684 | T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27959684 | PubMed |
| 9 | 24163303 | Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study. | Pathol Oncol Res | 2014 | https://conductscience.org/library/papers/24163303 | PubMed |
| 10 | 27412392 | Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade. | Oncologist | 2016 | https://conductscience.org/library/papers/27412392 | PubMed |
| 11 | 12820727 | MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment. | Glycoconj J | 2001 | https://conductscience.org/library/papers/12820727 | PubMed |
| 12 | 1574121 | Coley's toxins in perspective. | Nature | 1992 | https://conductscience.org/library/papers/1574121 | PubMed |
| 13 | 16003736 | Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy. | Int J Cancer | 2006 | https://conductscience.org/library/papers/16003736 | PubMed |
| 14 | 19697355 | Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion. | J Surg Oncol | 2009 | https://conductscience.org/library/papers/19697355 | PubMed |
| 15 | 18650514 | Sorafenib in advanced hepatocellular carcinoma. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18650514 | PubMed |
| 16 | 15375495 | Fas ligand expression in human pancreatic cancer. | Oncol Rep | 2004 | https://conductscience.org/library/papers/15375495 | PubMed |
| 17 | 10573518 | Cholangiocarcinomas express Fas ligand and disable the Fas receptor. | Hepatology | 1999 | https://conductscience.org/library/papers/10573518 | PubMed |
| 18 | 12947224 | Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation. | Immunol Res | 2003 | https://conductscience.org/library/papers/12947224 | PubMed |
| 19 | 23657083 | A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. | Ann Surg | 2013 | https://conductscience.org/library/papers/23657083 | PubMed |
| 20 | 26541606 | Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. | Science | 2015 | https://conductscience.org/library/papers/26541606 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42201494 | Early Tumor Shrinkage and Clinical Outcomes for Esophageal Squamous Cell Carcinoma Patients Treated with Immune Checkpoint Inhibitors: Real-World Observational Study. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42201494 | PubMed |
| 42098187 | PD-L1-positive circulating tumor cells associate with tumor malignancy and impaired circulating immunity in patients with gastrointestinal tumors. | Sci Rep | 2026 | https://conductscience.org/library/papers/42098187 | PubMed |
| 41710281 | Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3). | Immunotargets Ther | 2026 | https://conductscience.org/library/papers/41710281 | PubMed |
| 41003004 | Paradoxical Regulation of α7nAChR and NLRP3 Inflammasome in Gastrointestinal Cancers and Ulcerative Colitis. | Metabolites | 2025 | https://conductscience.org/library/papers/41003004 | PubMed |
| 40211993 | Advanced Technologies for Cancer Immunotherapy: Focus on Gastrointestinal Cancers. | Anticancer Agents Med Chem | 2025 | https://conductscience.org/library/papers/40211993 | PubMed |
| 39001441 | Challenges and Opportunities for Precision Surgery for Colorectal Liver Metastases. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39001441 | PubMed |
| 38994154 | Visualization analysis of research hotspots and trends on gastrointestinal tumor organoids. | World J Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/38994154 | PubMed |
| 38533510 | Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy. | Front Immunol | 2024 | https://conductscience.org/library/papers/38533510 | PubMed |
| 38421531 | Body Composition and Clinical Outcomes in Esophageal Cancer Patients Treated with Immune Checkpoint Inhibitors. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/38421531 | PubMed |
| 38370364 | LncRNA-MUF: A Novel Oncogenic Star with Potential as a Biological Marker and Therapeutic Target for Gastrointestinal Malignancies. | J Cancer | 2024 | https://conductscience.org/library/papers/38370364 | PubMed |
| 37422529 | C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer. | Br J Cancer | 2023 | https://conductscience.org/library/papers/37422529 | PubMed |
| 37373091 | Vista of the Future: Novel Immunotherapy Based on the Human V-Set Immunoregulatory Receptor for Digestive System Tumors. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37373091 | PubMed |
| 36599917 | Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer. | Br J Cancer | 2023 | https://conductscience.org/library/papers/36599917 | PubMed |
| 36261831 | Tumor buster - where will the CAR-T cell therapy 'missile' go? | Mol Cancer | 2022 | https://conductscience.org/library/papers/36261831 | PubMed |
| 36185433 | Coating bacteria for anti-tumor therapy. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36185433 | PubMed |
| 35121724 | A Review of Emerging Biomarkers for Immune Checkpoint Inhibitors in Tumors of the Gastrointestinal Tract. | Med Sci Monit | 2022 | https://conductscience.org/library/papers/35121724 | PubMed |
| 33643302 | Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy. | Front Immunol | 2020 | https://conductscience.org/library/papers/33643302 | PubMed |
| 33176601 | RAI14 Is a Prognostic Biomarker and Correlated With Immune Cell Infiltrates in Gastric Cancer. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/33176601 | PubMed |
| 32772210 | TNM staging for GIT cancers is correlated with the level of MMPs and TGF-β1. | Clin Exp Med | 2020 | https://conductscience.org/library/papers/32772210 | PubMed |
| 32592066 | Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma. | J Cancer Res Clin Oncol | 2020 | https://conductscience.org/library/papers/32592066 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28736635
GET https://conductscience.org/api/papers/v1/28736635/references?page=2